Iris Breitkreutz

Role of B-Cell–Activating Factor in Adhesion and Growth of Human Multiple Myeloma Cells in the Bone Marrow Microenvironment

Yu‐Tzu Tai, Xianfeng Li, Iris Breitkreutz et al. · Cancer Research · 2006 · 242 citations

Life Sciences, Cell Biology, Molecular Biology +17

Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

Iris Breitkreutz, Marc S. Raab, Sonia Vallet et al. · Leukemia · 2008 · 209 citations

Medicine, Oncology, Pharmacology +16

Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40–Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications

Yu‐Tzu Tai, Xianfeng Li, Laurence Catley et al. · Cancer Research · 2005 · 166 citations · Full text

Medicine, Immunology, Pharmacology +16

MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts

Sonia Vallet, Noopur Raje, Kenji Ishitsuka et al. · Blood · 2007 · 150 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma

H M Lokhorst, Ingo GH Schmidt-Wolf, Pieter Sonneveld et al. · Haematologica · 2007 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14